instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Regulatory Affairs,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I am writing to raise two distinct concerns. The first is a clinical information r... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended stora... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
Dear Quality and Commercial Teams,
I am the medical director of a residential care home group managing over 400 elderly residents and I am writing to formally report two issues. The first is a product complaint regarding Product A w... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the desiccant packet inside the bottle was torn and the contents had spilled over the tablets in a specific identified batch with quara... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Medical Director,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected patients. and I wish to raise two issues. The first concerns medical information about Product A specifical... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the established dosing inte... |
SUBJECT: Cross-product clinical and quality note on Product A and supply inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the clinical lead at a geriatric medicine service and I have two distinct issues to address. The first concerns Product A where The patient is a 54 year old male with type 1 diabetes... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the individual had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention taken, qual... |
SUBJECT: Inquiry and feedback about Product A and supply inquiry
BODY:
Dear Post-Market Surveillance,
I am the quality officer at a private hospital and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 49 year old female with Crohn disea... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient experienced acute chest pain radiating to the left arm within 4 hours of the dose temporally associated with Product A initiation, with clinical int... |
SUBJECT: Urgent concern regarding Product A and institutional contract enquiry
BODY:
Dear Quality Officer,
I am the clinical lead pharmacist at a large teaching hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 25mg where the barcode on the outer packag... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the barcode on the outer packaging failed to scan at three separate pharmacy workstations in a specific identified batch with quarantin... |
SUBJECT: Patient feedback concerning Product A and supply inquiry
BODY:
Dear Customer Support,
I am the medical director of a residential care home group managing over 400 elderly residents and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 66 ye... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical intervention ta... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Quality Officer,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I need to address two issues simultaneously. The first is a med... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you send any recent peer-revi... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clini... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I wish to bring two issues to y... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Safety and quality note on Product A and supply inquiry
BODY:
Dear Quality and Commercial Teams,
As the formulary coordinator for a 300-bed community hospital and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 29 year old male with a histor... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical intervention t... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Quality Officer,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. I have two separate matters to raise. Firstly regarding Product A I wo... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailab... |
SUBJECT: Urgent concern regarding Product A and institutional inquiry
BODY:
Dear Medical Information Team,
I am the chief pharmacist at a district general hospital and I have two distinct issues to address. Regarding Product A for formulary evaluation, Please provide the recommended storage temperature and light-prote... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended storage tempe... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Patient Support,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I wish to bring two matters to your attention. The first is a quality assurance issue with Product A 25mg where several tablets... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where several tablets were chipped along the edges and had an off-white discoloration inconsistent with the product specification in a specif... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I am writing to formally raise two matters. The first concerns Product A and spec... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on ... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
Dear Quality Assurance Team,
I am the prescribing advisor for a mental health trust and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Please provide the immunogeni... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity risk asses... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I need to bring two matters to your attentio... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinica... |
SUBJECT: Administrative and medical query on Product A and supply inquiry
BODY:
Dear Customer Support,
I am the clinical pharmacy specialist in a busy emergency department and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 57 year old male with slee... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the subject experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical intervention ta... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
To Whom It May Concern,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 53 yea... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with clinical in... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Post-Market Surveillance,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I am writing to report two se... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the subject had an anaphylactic reaction with throat swelling and difficulty breathing temporally associated with Product A initiation, with clinica... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Regulatory Affairs,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I am wr... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Clinical Affairs,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I need to address two issues simultaneously. The f... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A have any known inter... |
SUBJECT: Dual product inquiry and report about Product A and supply inquiry
BODY:
Dear Drug Safety and Medical Information,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient noticed yellowing of sclera and skin suggestive of hepatic involvement after 10 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Patient Support,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I need to address two separate issues. Regarding Product A our c... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the infusion instructions i... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Compliance Team,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I need to bring two matters to your attention. Regarding... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Dual product inquiry and report about Product A and institutional inquiry
BODY:
Dear Regulatory Affairs,
I am the chief pharmacist at a district general hospital and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the bioequivalence data for the gene... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Clinical Affairs,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. and I am writing to formally report two distinct matters. Regarding Produ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Issue documented with Product A and institutional contract enquiry
BODY:
Dear Pharmacy Director,
I am the medical director of a specialist cardiovascular centre and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the tablets i... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the tablets in the current batch are a visibly darker shade than all previous batches of the same strength in a specific identified bat... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the chief pharmacist at a district general hospital and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspe... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the aluminum foil backing peeled away too easily, compromising the integrity of individual blisters in a specific identified batch with... |
SUBJECT: Labeling error and clinical query about Product A and institutional contract enquiry
BODY:
Dear Drug Safety and Medical Information,
I am the clinical lead pharmacist at a large teaching hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the cap of the dropper bottle was cross-threaded and could not be sealed tightly after opening in a specific identified batch with quar... |
SUBJECT: Distribution and side-effect profile of Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am the head of formulary and medicines optimisation for an integrated care board and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our m... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing interval for ... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I am writing to report two s... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient reported severe muscle pain with elevated creatine kinase levels on day 9 temporally associated with Product A initiation, with clinical... |
SUBJECT: Patient feedback concerning Product A and institutional contract enquiry
BODY:
Dear Regulatory Affairs,
I am the chief pharmacist at a district general hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection of ou... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the prefilled pen device emitted an audible click but did not deliver the full dose when activated in a specific identified batch with ... |
SUBJECT: Complex issue involving Product A and supply inquiry
BODY:
Dear Patient Support,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 76 year old male with polymyalgia r... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Request for details about Product A and supply inquiry
BODY:
Dear Drug Safety Department,
I am writing as the clinical coordinator for a multi-site renal network and I have two distinct issues to address. The first concerns Product A where The patient is a 71 year old male with benign prostatic hyperplasia. H... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient reported hallucinations and confusion beginning on day 4 of the regimen temporally associated with Product A initiation, with clinical intervention ... |
SUBJECT: Packaging defect and dosing question for Product A and institutional inquiry
BODY:
Dear Customer Support,
I am the clinical pharmacist for a long-term care facility and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Can you confirm the s... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and beyond-us... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Quality and Commercial Teams,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. I have two distinct concerns to raise. The... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient reported dizziness and orthostatic hypotension after 2 doses temporally associated with Product A initiation, with clinical intervention... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Pharmacovigilance Team,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. and I need to address two issues simultaneously. The fi... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Medical Director,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am writing to formally raise two matters. The first... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dos... |
SUBJECT: Issue reported with Product A and institutional inquiry
BODY:
Dear Healthcare Liaison,
I am the ward manager on a busy medical unit and I have two distinct issues to address. Regarding Product A for formulary evaluation, Is there any guidance on Product A use in patients with prior severe cutaneous adverse re... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A use in pa... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Safety Team,
As the head of pharmacy procurement for a regional health trust and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the accom... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the accompanying patient leaflet was missing entirely from 2 of the 5 cartons delivered in a specific identified batch with quarantined... |
SUBJECT: Integrated feedback regarding Product A and institutional inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Does Product A r... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal function monito... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I need to address two issues simultaneously. The first is... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Labeling error and clinical query about Product A and institutional contract enquiry
BODY:
Dear Medical Information Team,
As the head of pharmacy procurement for a regional health trust and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine di... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the inhaler canister appeared dented and the counter mechanism was frozen at 0 doses remaining in a specific identified batch with quar... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I need to address two separate ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing inter... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the prescribing advisor for a mental health trust and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 31 year old female with lu... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient noticed yellowing of sclera and skin suggestive of hepatic involvement after 10 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Urgent concern regarding Product A and institutional contract enquiry
BODY:
Dear Product Team,
I am the lead clinical pharmacist at a regional oncology unit and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the foil strip was partially cut at... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure patients during handling in a specific identified b... |
SUBJECT: Issue reported with Product A and institutional inquiry
BODY:
Dear Medical Information and Safety Team,
I am the lead clinical pharmacist at a regional oncology unit and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Is there any real-wor... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on the long... |
SUBJECT: Request for details about Product A and institutional inquiry
BODY:
Dear Clinical Coordinator,
I am writing as the clinical coordinator for a multi-site renal network and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Is there any guidance on Product... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A use in pa... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. I have two distinct concerns to raise. The first is an adverse reaction my patie... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient reported severe muscle pain with elevated creatine kinase levels on day 9 temporally associated with Product A initiation, with clinical... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Customer Support,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I am writing to raise two distinct concerns. The first is a clinical information requ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Quality and Commercial Teams,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. I have two distinct concerns to raise. The fir... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinic... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Medical Affairs,
I am the ward manager on a busy medical unit where several inindividuals are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I am writing to raise two distinct conc... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for ... |
SUBJECT: Observation during use of Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The individual is a 35 year old fem... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Medical Director,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am formally reporting two concerns. The first is a safety issue... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Cross-product clinical and quality note on Product A and supply inquiry
BODY:
Dear Quality and Commercial Teams,
As the head of pharmacy procurement for a regional health trust and I have two distinct issues to address. The first concerns Product A where The patient is a 66 year old male with chronic lymphocy... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Quality Officer,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I need to address two separate issues. R... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on ... |
SUBJECT: Packaging defect and dosing question for Product A and institutional contract enquiry
BODY:
Dear Medical Director,
As the formulary coordinator for a 300-bed community hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the child-resistant cap failed to engage properly, raising serious safety concerns for household storage in a specific identified batch... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Medical Affairs,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. and I need to address two issues simultaneously. The firs... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share the patient-reported ... |
SUBJECT: Clarification sought on Product A and institutional inquiry
BODY:
Dear Medical Information and Safety Team,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy category and... |
SUBJECT: Cross-product clinical and quality note on Product A and institutional inquiry
BODY:
Dear Quality Officer,
I am the clinical pharmacy specialist in a busy emergency department and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically What is the... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Unexpected reaction linked to Product A and institutional contract enquiry
BODY:
To Whom It May Concern,
I am the clinical lead at a geriatric medicine service and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection of our... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the ampoule neck shattered during attempted opening despite following the recommended technique in a specific identified batch with qua... |
SUBJECT: Multi-faceted concern about Product A and institutional contract enquiry
BODY:
Dear Patient Support,
I am the lead clinical pharmacist at a regional oncology unit and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the foil strip was partially cut at... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure patients during handling in a specific identified b... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I wish to raise two issues simultaneously. The first is an ad... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from persistent headaches that increased in intensity over 5 days temporally associated with Product A initiation, with clinica... |
SUBJECT: Supply and experience review of Product A and institutional inquiry
BODY:
Dear Regulatory Affairs,
I am the ward manager on a busy medical unit and I have two distinct issues to address. Regarding Product A for formulary evaluation, What is the bioequivalence data for the generic formulation of Product A comp... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the bioequivalence data for the gene... |
SUBJECT: Unexpected reaction linked to Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I need to bring two matters to y... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinica... |
SUBJECT: Clinical observation with Product A and institutional inquiry
BODY:
Dear Healthcare Liaison,
I am the lead clinical pharmacist at a regional oncology unit and I have two distinct issues to address. Regarding Product A for formulary evaluation, Is there a black box warning or regulatory safety communication fo... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there a black box warning or regulatory s... |
SUBJECT: Comprehensive inquiry on Product A and institutional contract enquiry
BODY:
Dear Drug Safety and Medical Information,
I am the chief pharmacist at a district general hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing in... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the aluminum foil backing peeled away too easily, compromising the integrity of individual blisters in a specific identified batch with... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Quality and Commercial Teams,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I am writing to report two separate issues. The ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient observed blood in urine after 4 days of administration temporally associated with Product A initiation, with clinical intervention and i... |
SUBJECT: Request for details about Product A and institutional inquiry
BODY:
Dear Quality Officer,
I am the clinical lead pharmacist at a large teaching hospital and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What monitoring parameters are recommended dur... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recommended d... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Drug Safety Department,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I need to bring two matters to your attention. Reg... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient reported visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, wit... |
SUBJECT: Cross-product clinical and quality note on Product A and institutional contract enquiry
BODY:
Dear Medical and Commercial Teams,
I am the medical director of a residential care home group managing over 400 elderly residents and I am writing to formally raise two separate matters. The first is a product qualit... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the syringe plunger was stuck and could not be depressed smoothly, suggesting a manufacturing defect in a specific identified batch wit... |
SUBJECT: Integrated feedback regarding Product A and institutional inquiry
BODY:
To Whom It May Concern,
I am the head of formulary and medicines optimisation for an integrated care board and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What monitoring para... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recommended d... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Medical Information Team,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected patients. and I am writing to formally raise two matters. The first concerns Product A and specific... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A have any known intera... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Quality Assurance Team,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I need to bring two matters to your attention. Regarding Product A The ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. I have two separate matt... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipide... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the subject reported visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, wit... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Clinical Affairs,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I wish to raise two issues. The first concerns medical information ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require renal functi... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I am writing to raise two distinct concerns. The first is a clinica... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Patient Support,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection of our curr... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the batch number on the vial label did not match the corresponding entry in the electronic pedigree system in a specific identified bat... |
SUBJECT: Joint product evaluation and safety report for Product A and supply inquiry
BODY:
Dear Post-Market Surveillance,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patien... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical intervention take... |
SUBJECT: Cross-product clinical and quality note on Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory co... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for Product ... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Pharmacy Director,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I wish to raise two issues simultaneously. The first is an adverse event report for Prod... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Medical Director,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am writing to raise two distinct concerns. The first is a clinical ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity ri... |
SUBJECT: Combined quality and clinical report for Product A and institutional inquiry
BODY:
Dear Patient Safety and Market Access Team,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to raise two separate matters. The first is a clinical information request regarding Product A... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide guidance on dose tapering ... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. I have two separate matters to raise. Fir... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the mechanism of action for ... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Regulatory Affairs,
I am the ward manager on a busy medical unit and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the child-resistant cap failed to engag... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the child-resistant cap failed to engage properly, raising serious safety concerns for household storage in a specific identified batch... |
SUBJECT: Multi-faceted concern about Product A and institutional inquiry
BODY:
Dear Pharmacovigilance Team,
I am the director of pharmacy for a network of community hospitals and I have two distinct issues to address. Regarding Product A for formulary evaluation, Could you clarify the pregnancy category and any terato... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy category and... |
SUBJECT: Inquiry and feedback about Product A and institutional contract enquiry
BODY:
Dear Quality Assurance Team,
I am the prescribing advisor for a mental health trust and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the aluminum... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the aluminum foil backing peeled away too easily, compromising the integrity of individual blisters in a specific identified batch with... |
SUBJECT: Urgent concern regarding Product A and institutional contract enquiry
BODY:
Dear Medical Director,
I am the chief pharmacist at a district general hospital and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the aluminum foil ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the aluminum foil backing peeled away too easily, compromising the integrity of individual blisters in a specific identified batch with... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I need to... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient observed blood in urine after 4 days of administration temporally associated with Product A initiation, with clinical intervention and i... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Customer Support,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. I have two separate problems to raise. The first is a clinical inform... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any guidance on dose modif... |
SUBJECT: Unexpected reaction linked to Product A and institutional inquiry
BODY:
Dear Clinical Affairs,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advis... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A use in pa... |
SUBJECT: Co-therapy observation and commercial query on Product A and supply inquiry
BODY:
Dear Pharmacovigilance Team,
I am the quality officer at a private hospital and I wish to bring two matters to your attention. The first is an adverse reaction report mattering Product A where The patient is a 66 year old male w... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Clarification sought on Product A and supply inquiry
BODY:
Dear Patient Support,
I am the nurse practitioner in a busy GP practice and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 33 year old female with multiple sclerosis on immunomodulatory ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient experienced acute chest pain radiating to the left arm within 4 hours of the dose temporally associated with Product A initiation, with clinical int... |
SUBJECT: Co-therapy observation and commercial query on Product A and institutional inquiry
BODY:
Dear Medical Information and Safety Team,
I am the prescribing advisor for a mental health trust and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Could you pro... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide guidance on dose tapering ... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Safety Team,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I wish to bring two issues to your attention. The first is... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy cate... |
SUBJECT: Complex issue involving Product A and supply inquiry
BODY:
Dear Pharmacy Director,
As the formulary coordinator for a 300-bed community hospital and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 45 year old male with no known drug allergies. He... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from persistent headaches that increased in intensity over 5 days temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Medical Director,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. and I wish to bring two issues to your attention. The first is a medical inf... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinica... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I wish to raise two issues. The first concerns medical information... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share the patient-documente... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.